Applying Eye-Gaze Assistive Technology for Children and Youth With Complex Needs

NCT04377893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2021-09-27

No results posted yet for this study

Summary

The purpose of this research is to investigate the impacts of applying eye-gaze assistive technology (AT) in children and youth with severe disabilities and complex needs in Taiwan, where eye-gaze AT has not been researched for children yet.

Conditions

  • Self-Help Devices
  • Eye-Gaze Technology
  • Severe Physical Disabilities
  • Communication Disorders

Interventions

DEVICE

Eye gaze AT intervention

The eye-gaze AT intervention includes eye-gaze AT and service delivery to support the participants using this technology in daily life. The Tobii PCEye Mini (Tobii, Danderyd, Sweden) and specialized software are applied with adaptation to meet each child's individual needs. To ensure the consistency of service delivery, two-day courses are conducted before the intervention. The participant's teachers or parents are invited as the main interventionist to facilitate the child's usage of eye-gaze AT in daily life under team support. The service delivery involves parents in joint goal-setting, planning, and jointly review the progress of the usage of eye-gaze AT as a family-centered practice. Individual meetings and individual supports are provided during intervention periods. The collaborative team will perform biweekly follow-up contacts during intervention periods. The researcher will conduct the fidelity checklist every month to determine the extent of treatment integrity.

Sponsors & Collaborators

  • Chang Gung University

    collaborator OTHER
  • Jonkoping University

    collaborator OTHER
  • Folke Bernadotte Stiftelsen

    collaborator UNKNOWN
  • Stiftelsen Kempe-Carlgrenska Fonden

    collaborator UNKNOWN
  • Stiftelsen Clas Groschinskys Minnesfond

    collaborator UNKNOWN
  • Helge Ax:son Johnsons Stiftelse

    collaborator UNKNOWN
  • Yu-Hsin Hsieh

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-19
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04377893 on ClinicalTrials.gov